Press Release – New York, NY – December 16, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, in its recent $3.5 million registered direct offering.
The SRFC team was led by partners Gregory Sichenzia and Avital Perlman, with associate Benasz Hansotia.